ConductScience.org, home

Paper600314

Effect of entekohepatic circulation on the pharmacokinetics of spironolactone in man.

Abshagen U and 3 others. Naunyn Schmiedebergs Arch Pharmacol, 1977. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Effect of entekohepatic circulation on the pharmacokinetics of spironolactone in man. Papers, record 600314. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/600314

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of entekohepatic circulation on the pharmacokinetics of spironolactone in man.
PubMed
Journal
Naunyn Schmiedebergs Arch Pharmacol
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
1.01
iCite
Revised in PubMed
2019-07-25
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Abshagen UU
2von Grodzicki UU
3Hirschberger UU
4Rennekamp HH

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Enterohepatic CirculationMajor topic
SpironolactoneMajor topic
Aged
Bile
Female
Half-Life
Humans
Kinetics
Male
Middle Aged
Time Factors

Source PubMed

Download CSV of topics

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15042701Isolation and identification of novel sulfur-containing metabolites of spironolactone (Aldactone).Steroids1972https://conductscience.org/library/papers/5042701PubMed
24699222Preparation of metabolites of spironolactone by microbial oxygenation.Appl Microbiol1973https://conductscience.org/library/papers/4699222PubMed
34712657Pharmacokinetics of spironolactone, canrenone and canrenoate-K in humans.J Pharmacol Exp Ther1973https://conductscience.org/library/papers/4712657PubMed
4856602Disposition kinetics of spironolactone in hepatic failure after single doses and prolonged treatment.Eur J Clin Pharmacol1977https://conductscience.org/library/papers/856602PubMed
51012347Pharmacokinetics of spironolactone in man.Naunyn Schmiedebergs Arch Pharmacol1976https://conductscience.org/library/papers/1012347PubMed
6857172Formation of chlorpromazine sulphoxide and monodesmethylchlorpromazine by microsomes of small intestine.Naunyn Schmiedebergs Arch Pharmacol1977https://conductscience.org/library/papers/857172PubMed
713705355The enzymatic formation of sulfoxides: the oxidation of chlorpromazine and 4,4'-diaminodiphenyl sulfide by guinea pig liver microsomes.J Pharmacol Exp Ther1960https://conductscience.org/library/papers/13705355PubMed
84276758Conversion of spironolactone to canrenone and disposition kinetics of spironolactone and canrenoate-potassium in rats.Naunyn Schmiedebergs Arch Pharmacol1974https://conductscience.org/library/papers/4276758PubMed
95044815Plasma levels of spirolactones in the dog.J Pharm Sci1972https://conductscience.org/library/papers/5044815PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
33152344Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections.Biochem Pharmacol2021https://conductscience.org/library/papers/33152344PubMed
32799863Preclinical study of simultaneous pharmacokinetic and pharmacodynamic herb-drug interactions between Yin-Chen-Hao-Tang and spironolactone.BMC Complement Med Ther2020https://conductscience.org/library/papers/32799863PubMed
12162761Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.Clin Pharmacokinet2002https://conductscience.org/library/papers/12162761PubMed
6993083Clinical pharmacokinetics of diuretics.Clin Pharmacokinet1980https://conductscience.org/library/papers/6993083PubMed
6617730Preliminary observations on the biliary elimination of mebendazole and its metabolites in patients with echinococcosis.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6617730PubMed
3396618The effect of renal and hepatic impairment and of spironolactone on digoxin immunoassays.Eur J Clin Pharmacol1988https://conductscience.org/library/papers/3396618PubMed
1606994Digoxin-interactions in man: spironolactone reduces renal but not biliary digoxin clearance.Eur J Clin Pharmacol1992https://conductscience.org/library/papers/1606994PubMed
389528Biliary excretion of drugs in man.Clin Pharmacokinet1979https://conductscience.org/library/papers/389528PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/600314

GET https://conductscience.org/api/papers/v1/600314/authors